XML 43 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2018
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis The following table presents the Company’s financial instruments that are measured at fair value on a recurring basis by their valuation hierarchy levels as of the dates indicated:
 
December 31, 2018
 
December 31, 2017
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
Assets carried at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments in debt securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MBS
$
3,749,464

 
$

 
$
3,747,190

 
$
2,274

 
$
3,026,989

 
$

 
$
3,019,746

 
$
7,243

U.S. Treasuries

 

 

 

 
146,530

 
146,530

 

 

Derivative assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps
324

 

 
324

 

 
791

 

 
791

 

Eurodollar futures

 

 

 

 
666

 
666

 

 

TBA securities
6,239

 

 
6,239

 

 
1,483

 

 
1,483

 

Total assets carried at fair value
$
3,756,027

 
$

 
$
3,753,753

 
$
2,274

 
$
3,176,459

 
$
147,196

 
$
3,022,020

 
$
7,243

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities carried at fair value:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury futures
$
1,218

 
$
1,218

 
$

 
$

 
$

 
$

 
$

 
$

TBA securities

 

 

 

 
269

 

 
269

 

Total liabilities carried at fair value
$
1,218

 
$
1,218

 
$

 
$

 
$
269

 
$

 
$
269

 
$


Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation The activity of the Company’s non-Agency MBS measured at fair value on a recurring basis using Level 3 inputs is presented in the following table for the periods indicated:
 
Year Ended
 
December 31,
 
2018
 
2017
Balance as of beginning of period
$
7,243

 
$
10,927

Unrealized loss included in OCI
(1,850
)
 
(1,733
)
Principal payments
(5,071
)
 
(4,351
)
Accretion
1,952

 
2,400

Balance as of end of period
$
2,274

 
$
7,243



Fair Value, by Balance Sheet Grouping The following table presents a summary of the carrying value and estimated fair values of the Company’s financial instruments as of the dates indicated:
 
December 31, 2018
 
December 31, 2017
 
Carrying Value
 
Fair Value
 
Carrying Value
 
Fair Value
Assets:
 
 
 
 
 
 
 
Mortgage-backed securities
$
3,749,464

 
$
3,749,464

 
$
3,026,989

 
$
3,026,989

U.S. Treasuries

 

 
146,530

 
146,530

Mortgage loans held for investment, net (1)
11,527

 
8,566

 
15,738

 
12,973

Derivative assets
6,563

 
6,563

 
2,940

 
2,940

Liabilities:
 

 
 

 
 

 
 

Repurchase agreements (2)
$
3,267,984

 
$
3,267,984

 
$
2,565,902

 
$
2,565,902

Non-recourse collateralized financing (1)
3,458

 
3,475

 
5,520

 
5,554

Derivative liabilities
1,218

 
1,218

 
269

 
269


(1)
The Company determines the fair value of its mortgage loans held for investment, net and its non-recourse collateralized financing using internally developed cash flow models with inputs similar to those used to estimate the fair value of the Company’s Level 3 non-Agency MBS.
(2)
The carrying value of repurchase agreements generally approximates fair value due to their short-term maturities.